MDRNA’s generic calcitonin-salmon nasal spray is the generic equivalent of Miacalcin marketed by Novartis Pharmaceuticals. Full FDA approval would follow the completion of Apotex’s 180-day exclusivity period, or
Genzyme will commercialize Mozobil in the US through a blood and marrow transplant sales force that is part of the company’s transplant and oncology business unit. Genzyme has
Under the agreement, Yakult will pay Celsion licensing fees to acquire the rights to ThermoDox for the Japanese market. An amount of $2.5 million will be paid immediately,
According to the company, the Express SD Renal stent is designed specifically for treatment of the renal arteries by incorporating additional connections in the proximal end of the
The company continues to anticipate that the resubmission, which includes a risk evaluation and mitigation strategy for Onsolis, will be approved in the first half of 2009. Onsolis
This study aims to evaluate the safety and efficacy of (18F)-ML-10 in early assessment of response of metastatic brain tumors to high-dose, single-fraction radiotherapy (also known as stereotactic
The FDA’s approval of Trilipix was based on the largest clinical trial program to date designed to evaluate the efficacy and safety of a fibrate in combination with
Citi said that its wide acceptance and ability to integrate fully with Schering-Plough’s internal payment and expense management systems will enable Schering-Plough to streamline its corporate, purchasing and
As chief marketing officer (CMO), Mr Blumenfield has overall responsibility for Prime’s marketing strategy, product development and other market-related initiatives. He will focus on continuing Prime’s expansion and
As a consequence, Alchemia will receive payments totaling $1.62 million from Dr Reddy’s, its manufacturing and marketing partner. Approximately $1 million will be received in December 2008 and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.